The Supreme Court is torn over Purdue Pharma’s opioid settlement
One thing seems clear: the justices want to do right by the victims of the opioid epidemic. They have little sympathy for the Sacklers, the family who owned Purdue when it launched OxyContin in 1996 and profited immensely from the painkiller—despite evidence that it was highly addictive and destroying lives.